Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Regeneron Pharma bags USFDA nod for Evkeeza for young children with ultra-rare form of cholesterol

Ruchika Sharma23 March 2023 10:00 AM IST

Homozygous familial hypercholesterolemia occurs when two copies of the FH-causing genes are inherited, one from each parent, resulting in dangerously...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis not to move ahead with UK trial of anti-cholesterol drug Leqvio

Ruchika Sharma22 March 2023 4:00 PM IST

Berlin: Novartis said on Wednesday that it had decided not to move forward with ORION-17, the UK-based primary prevention trial originally...

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

Roche collaborates with Eli Lilly to enhance early diagnosis of Alzheimer's disease

Ruchika Sharma22 March 2023 3:00 PM IST

Basel: Roche has announced that it has entered into a collaboration with Eli Lilly and Company to support the development of Roche’s Elecsys Amyloid...

USFDA nod to citrate free high concentration formulation of biosimilar Hyrimoz injection: Sandoz

Ruchika Sharma22 March 2023 1:45 PM IST

Sandoz intends to launch the Hyrimoz citrate-free HCF in the US on July 1, 2023.

Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

Sanofi Dupixent gets European Commission nod for children aged 6 months to 5 years old with severe atopic dermatitis

Ruchika Sharma22 March 2023 12:45 PM IST

Dupixent is an injection administered under the skin at different injection sites.

Lupin gets USFDA approval for generic equivalent of Rexulti Tablets

Ruchika Sharma22 March 2023 11:45 AM IST

This product would be manufactured at Lupin's Pithampur facility in India.

Zydus Lifesciences arm bags USFDA nod for ulcerative colitis drug Tofacitinib

Ruchika Sharma22 March 2023 10:00 AM IST

Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis and for the treatment of adult...

Gilead Sciences gets USFDA nod for new Biktarvy indication

Gilead Sciences exercises option to license Nurix's investigational targeted protein degrader molecule NX-0479

Ruchika Sharma21 March 2023 5:22 PM IST

Foster City: Gilead Sciences, Inc. and Nurix Therapeutics, Inc., a clinical-stage biopharmaceutical company developing targeted protein...

Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case Study

Glenmark Pharma gets final USFDA nod for Schizophrenia drug Prochlorperazine Maleate

Ruchika Sharma21 March 2023 4:00 PM IST

Mumbai: Glenmark Pharmaceuticals Ltd. has announced that the company has received final approval from the United States Food & Drug Administration...

Granules India inaugurates two advanced Centres of Excellence at IIT Hyderabad

Granules India's step-down subsidiary completes USFDA audit with zero observations

Ruchika Sharma21 March 2023 2:55 PM IST

Hyderabad: Granules India has announced that Granules Consumer Health Inc., a stepdown subsidiary of the Company and a wholly owned subsidiary of...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

BioNTech, OncoC4 collaborate to co-develop and commercialize novel checkpoint antibody in multiple solid tumor indications

Ruchika Sharma21 March 2023 2:15 PM IST

Under the terms of the agreement, OncoC4 will receive a $200 million upfront payment and is eligible to receive development, regulatory and commercial...

Concert Pharma Deuruxolitinib significantly improves scalp hair regrowth in Alopecia areata, reveals data

Ruchika Sharma21 March 2023 1:15 PM IST

Deuruxolitinib is an investigational oral selective inhibitor of Janus kinases JAK1 and JAK2.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok